Clinical Trials List
2011-05-23 - 2012-10-31
Phase III
Terminated4
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Yao Huang Division of Endocrinology
- Shu-Fu Lin Shu-Fu Lin Division of Endocrinology
- 陳正友 Division of Endocrinology
- 林承緯 Division of Endocrinology
- 黃瓊慧 Division of Endocrinology
- Jia-Hong Lin Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
2767 participants
